Clinical Trial Update: Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy [Phase 1, Phase 2]

View source ↗

Summary

Completion of a Phase 1/2 trial evaluating intravitreal ranibizumab in combination with panretinal photocoagulation for proliferative diabetic retinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetic Retinopathy, Retinal Diseases | Phase 1, Phase 2 | Status: COMPLETED